{"entity":{"type":"insider","cik":"0001554537","url":"/insider/0001554537","json_url":"/insider/0001554537.json","name":"Mond James","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2014-05-16","last":"2020-09-10","span_basis":"filed_date"},"name_variants":[{"name":"Mond James","source":"filing","n_filings":8,"first_seen":"2014-05-16","last_seen":"2020-09-10"}],"transactions":[{"id":2816945,"accession":"0001193805-20-001129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-20-001129","line_url":"/filing/0001193805-20-001129#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001554537","owner_name":"Mond James","owner_display_name":"Mond James","owner_url":"/insider/0001554537","role":"Officer (EVP, CSO and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, CSO and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CSO and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":8800.0,"total_display":"8,800.00","total_whole":"8,800","shares_owned_after":73174.0,"shares_owned_after_display":"73,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-10","scope":"insider"},{"id":2757081,"accession":"0001193805-20-001003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-20-001003","line_url":"/filing/0001193805-20-001003","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001554537","owner_name":"Mond James","owner_display_name":"Mond James","owner_url":"/insider/0001554537","role":"Officer (EVP, CSO and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, CSO and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CSO and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":2.8785714285714286,"price_display":"2.88","price_state":"stated","total_value":20150.0,"total_display":"20,150.00","total_whole":"20,150","shares_owned_after":67174.0,"shares_owned_after_display":"67,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-10","filed_date":"2020-08-12","scope":"insider","n_lines":2},{"id":2223447,"accession":"0001193805-20-000133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-20-000133","line_url":"/filing/0001193805-20-000133#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001554537","owner_name":"Mond James","owner_display_name":"Mond James","owner_url":"/insider/0001554537","role":"Officer (CSO and CMO)","role_mark":"O","role_mark_label":"Officer (CSO and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4285.0,"shares_display":"4,285","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":14997.5,"total_display":"14,997.50","total_whole":"14,998","shares_owned_after":22174.0,"shares_owned_after_display":"22,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-11","filed_date":"2020-02-11","scope":"insider"},{"id":8723508,"accession":"0001193805-19-000522","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-19-000522","line_url":"/filing/0001193805-19-000522#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001554537","owner_name":"Mond James","owner_display_name":"Mond James","owner_url":"/insider/0001554537","role":"Officer (EVP, CSO and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, CSO and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CSO and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":18000.0,"total_display":"18,000.00","total_whole":"18,000","shares_owned_after":17889.0,"shares_owned_after_display":"17,889","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-17","filed_date":"2019-05-21","scope":"insider"},{"id":4073302,"accession":"0001193805-17-003449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-17-003449","line_url":"/filing/0001193805-17-003449#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001554537","owner_name":"Mond James","owner_display_name":"Mond James","owner_url":"/insider/0001554537","role":"Officer (EVP, CSO and CMO)","role_mark":"O","role_mark_label":"Officer (EVP, CSO and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CSO and CMO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":21500.0,"total_display":"21,500.00","total_whole":"21,500","shares_owned_after":13389.0,"shares_owned_after_display":"13,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-09","filed_date":"2017-11-13","scope":"insider"},{"id":2541642,"accession":"0001193805-16-003193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-16-003193","line_url":"/filing/0001193805-16-003193#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001554537","owner_name":"Mond James","owner_display_name":"Mond James","owner_url":"/insider/0001554537","role":"Officer (CSO/CMO)","role_mark":"O","role_mark_label":"Officer (CSO/CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO/CMO","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":770.0,"shares_display":"770","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":5005.0,"total_display":"5,005.00","total_whole":"5,005","shares_owned_after":3389.0,"shares_owned_after_display":"3,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-03","filed_date":"2016-05-05","scope":"insider"},{"id":8531397,"accession":"0001193805-15-000401","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-15-000401","line_url":"/filing/0001193805-15-000401#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001554537","owner_name":"Mond James","owner_display_name":"Mond James","owner_url":"/insider/0001554537","role":"Officer (CSO/CMO)","role_mark":"O","role_mark_label":"Officer (CSO/CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO/CMO","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250.0,"shares_display":"1,250","price_per_share":8.02,"price_display":"8.02","price_state":"stated","total_value":10025.0,"total_display":"10,025.00","total_whole":"10,025","shares_owned_after":2565.0,"shares_owned_after_display":"2,565","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-16","filed_date":"2015-03-18","scope":"insider"},{"id":7067538,"accession":"0001193805-14-001044","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-14-001044","line_url":"/filing/0001193805-14-001044#line-1","is_derivative":false,"issuer_cik":"0001368514","issuer_name":"ADMA BIOLOGICS, INC.","issuer_ticker":"ADMA","issuer_name_source":null,"issuer_url":"/issuer/0001368514","owner_cik":"0001554537","owner_name":"Mond James","owner_display_name":"Mond James","owner_url":"/insider/0001554537","role":"Officer (CSO/CMO)","role_mark":"O","role_mark_label":"Officer (CSO/CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO/CMO","security_title":"Common Stock, $0.0001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1315.0,"shares_display":"1,315","price_per_share":7.6,"price_display":"7.60","price_state":"stated","total_value":9994.0,"total_display":"9,994.00","total_whole":"9,994","shares_owned_after":1315.0,"shares_owned_after_display":"1,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-14","filed_date":"2014-05-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001368514","name":"ADMA BIOLOGICS, INC.","url":"/issuer/0001368514","role":"Officer (EVP, CSO and CMO)","n_filings":8,"first_seen":"2014-05-16","last_seen":"2020-09-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001554537","retrieved_at":"2026-08-23T08:58:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}